Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 16 March 2021
Accepted: 3 July 2021
First Online: 13 July 2021
Declarations
:
: Drs. Baughman and Lower have research grants from Mallinckrodt, Bayer, Genentech, Novartis, Celgene, aTYR. Dr. Baughman has been consultant for Novartis and Mallinckrodt and a speaker for Mallinckrodt. Jacob Kotzin has no conflicts.
: The study was approved by the University of Cincinnati Institutional Review Board and registered on ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT02356445).
